Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ortus Medical ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   11.2% 17.5% 10.5% 10.2% 23.8% 11.9% 17.5% 17.5%   Credit score (0-100)   23 10 23 23 3 19 9 9   Credit rating   BB B BB BB B BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   431 797 978 699 362 728 0.0 0.0   EBITDA   15.5 38.0 395 35.9 -306 309 0.0 0.0   EBIT   15.5 38.0 395 35.9 -306 309 0.0 0.0   Pre-tax profit (PTP)   9.1 35.7 387.3 42.0 -301.3 286.2 0.0 0.0   Net earnings   9.1 35.7 314.6 31.3 -235.2 223.0 0.0 0.0   Pre-tax profit without non-rec. items   9.1 35.7 387 42.0 -301 286 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -56.7 -20.9 294 212 -138 85.4 35.4 35.4   Interest-bearing liabilities   0.4 7.5 9.2 12.9 14.5 14.5 0.0 0.0   Balance sheet total (assets)   277 1,591 1,992 956 692 1,063 35.4 35.4   Net Debt   -228 -558 -249 -193 -110 -73.9 -35.4 -35.4     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   431 797 978 699 362 728 0.0 0.0   Gross profit growth   174.7% 85.0% 22.8% -28.6% -48.2% 101.0% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   277 1,591 1,992 956 692 1,063 35 35   Balance sheet change%   180.0% 474.7% 25.2% -52.0% -27.7% 53.7% -96.7% 0.0%   Added value   15.5 38.0 394.8 35.9 -305.9 308.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.6% 4.8% 40.3% 5.1% -84.5% 42.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.3% 4.0% 21.9% 3.4% -32.9% 33.2% 0.0% 0.0%   ROI %   28.2% 995.1% 254.4% 18.8% -245.6% 548.5% 0.0% 0.0%   ROE %   4.8% 3.8% 33.4% 12.4% -52.1% 57.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -17.0% -1.3% 14.7% 22.2% -16.6% 8.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,470.1% -1,466.0% -63.1% -538.9% 35.8% -23.9% 0.0% 0.0%   Gearing %   -0.6% -35.7% 3.1% 6.1% -10.6% 17.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.8% 81.8% 89.4% 68.8% 53.0% 189.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 1.0 1.2 1.3 0.8 0.9 0.0 0.0   Current Ratio   0.8 1.0 1.2 1.3 0.8 1.1 0.0 0.0   Cash and cash equivalent   228.5 565.0 258.2 206.3 124.2 88.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -56.7 -20.9 293.6 212.0 -137.6 85.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0